Xian Disai Biology Pharmaceutical Co. Ltd.

The main purpose of the study is to investigate the pharmacokinetic characteristics of Telmisartan Tablets (test preparation, specification: 80 mg) produced by Xi'an Disai Biopharmaceutical Co., Ltd. and Telmisartan Tablets (reference preparation, trade name: Mikasu®, specification: 80 mg) certified by Boehringer Ingelheim under the same conditions after a single oral administration in healthy subjects under fasting and postprandial conditions, evaluate the bioequivalence between the two preparations, and provide a basis for the consistency evaluation of the test preparation. Secondary purpose of the study is to investigate the safety of Telmisartan Tablets (test preparation, specification: 80 mg) produced by Xi'an Disai Biopharmaceutical Co., Ltd. and Telmisartan Tablets (reference preparation, trade name: Mikasu®, specification: 80 mg) certified by Boehringer Ingelheim under the same conditions after a single oral administration in healthy subjects under fasting and postprandial conditions.